CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: 2019-12-26

DOI: 10.1073/pnas.1910856117

Affiliations: 6

Authors: 12

Institutions	Authors	Share
ChemoCentryx, Inc., United States of America (USA)		0.33
Department of Pharmacology and Therapeutics, UF, United States of America (USA)		0.29
Edwin L. Steele Laboratories, MGH, United States of America (USA)		0.17
Department of Neuroscience, UF, United States of America (USA)		0.08
Preston A. Wells, Jr. Center for Brain Tumor Therapy, UF, United States of America (USA)		0.08
Lillian S. Wells Department of Neurosurgery, UF, United States of America (USA)		0.04

Return

Latest supplement

Nature Index 2020 South Korea

A concerted government push to make South Korea an innovation leader, backed by strong investment and systemic reform, has brought rapid and long-lasting results. The country’s scientific landscape is becoming more diverse and more productive, as a place where upwardly mobile researchers thrive.

Access free